Rajni Kannan on Managing Patients on Combination Immunotherapy
Rajni Kannan, BS, MS, RN, APN-BC, discusses the management of patients receiving combination immunotherapy.
Rajni Kannan, BS, MS, RN, ANP-BC, of NYU Langone—Perlmutter Cancer Center—discusses the importance of keeping up with patients who have received combination immunotherapy.
Combination immunotherapy can often have intense and quick-acting side effects, increasing the need for careful patient management. Rather than solely bringing patients back into the center for visits, nurses can use smartphones to keep in touch with patients, who can send photographs of rashes or other changes, for example. The key is strong patient education, to make patients aware of the importance of reporting their side effects as soon as possible.
Cemiplimab as Adjuvant Therapy Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma
January 20th 2025Adjuvant cemiplimab demonstrated a statistically significant improvement in DFS compared to placebo in post-surgical patients with high-risk CSCC, impacting post-operative care considerations.
